BFM
ETON icon

Boothbay Fund Management’s Eton Pharmaceutcials ETON Stock Holding History

Boothbay Fund Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.37M Buy
+55,605
New +$972K 0.02% 795
2019
Q1 		– Sell
-11,966
Closed -$73K – 792
2018
Q4 		$73K Buy
+11,966
New +$73.4K 0.01% 575

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Boothbay Fund Management's ETON Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Eton Pharmaceutcials (ETON) in Q1 2026: 55,605 shares worth $1.37M. The stake represents 0.02% of the portfolio and ranks #795 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in ETON as recently as Q4 2018.

Boothbay Fund Management first reported a position in ETON in Q4 2018 and has held it in 2 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Boothbay Fund Management held 55,605 shares of Eton Pharmaceutcials worth $1.37M as of Q1 2026.
  • Eton Pharmaceutcials was a new Boothbay Fund Management position in Q1 2026.
  • Eton Pharmaceutcials made up 0.02% of Boothbay Fund Management's portfolio in Q1 2026, its #795 holding.
  • Boothbay Fund Management first reported a position in Eton Pharmaceutcials in Q4 2018 and has held it in 2 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.